Cargando…
Systematic review of global hepatitis E outbreaks to inform response and coordination initiatives
INTRODUCTION: Hepatitis E virus (HEV) is the most common cause of acute hepatitis. While symptoms are generally mild and resolve within weeks, some populations (e.g., pregnant women, immunocompromised adults) are at high-risk of severe HEV-related morbidity and mortality. There has not been a recent...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259355/ https://www.ncbi.nlm.nih.gov/pubmed/37308896 http://dx.doi.org/10.1186/s12889-023-15792-8 |
_version_ | 1785057643555979264 |
---|---|
author | Al-Shimari, Fatima H. Rencken, Camerin A. Kirkwood, Carl D. Kumar, Ramya Vannice, Kirsten S. Stewart, Barclay T. |
author_facet | Al-Shimari, Fatima H. Rencken, Camerin A. Kirkwood, Carl D. Kumar, Ramya Vannice, Kirsten S. Stewart, Barclay T. |
author_sort | Al-Shimari, Fatima H. |
collection | PubMed |
description | INTRODUCTION: Hepatitis E virus (HEV) is the most common cause of acute hepatitis. While symptoms are generally mild and resolve within weeks, some populations (e.g., pregnant women, immunocompromised adults) are at high-risk of severe HEV-related morbidity and mortality. There has not been a recent comprehensive review of contemporary HEV outbreaks, which limits the validity of current disease burden estimates. Therefore, we aimed to characterize global HEV outbreaks and describe data gaps to inform HEV outbreak prevention and response initiatives. METHODS: We performed a systematic review of peer-reviewed (PubMed, Embase) and gray literature (ProMED) to identify reports of outbreaks published between 2011 and 2022. We included (1) reports with ≥ 5 cases of HEV, and/or (2) reports with 1.5 times the baseline incidence of HEV in a specific population, and (3) all reports with suspected (e.g., clinical case definition) or confirmed (e.g., ELISA or PCR test) cases if they met criterium 1 and/or 2. We describe key outbreak epidemiological, prevention and response characteristics and major data gaps. RESULTS: We identified 907 records from PubMed, 468 from Embase, and 247 from ProMED. We screened 1,362 potentially relevant records after deduplication. Seventy-one reports were synthesized, representing 44 HEV outbreaks in 19 countries. The populations at risk, case fatalities, and outbreak durations were not reported in 66% of outbreak reports. No reports described using HEV vaccines. Reported intervention efforts included improving sanitation and hygiene, contact tracing/case surveillance, chlorinating boreholes, and advising residents to boil water. Commonly missing data elements included specific case definitions used, testing strategy and methods, seroprevalence, impacts of interventions, and outbreak response costs. Approximately 20% of HEV outbreaks we found were not published in the peer-reviewed literature. CONCLUSION: HEV represents a significant public health problem. Unfortunately, extensive data shortages and a lack of standardized reporting make it difficult to estimate the HEV disease burden accurately and to implement effective prevention and response activities. Our study has identified major gaps to guide future studies and outbreak reporting systems. Our results support the development of standardized reporting procedures/platforms for HEV outbreaks to ensure accurate and timely data distribution, including active and passive coordinated surveillance systems, particularly among high-risk populations. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-023-15792-8. |
format | Online Article Text |
id | pubmed-10259355 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-102593552023-06-14 Systematic review of global hepatitis E outbreaks to inform response and coordination initiatives Al-Shimari, Fatima H. Rencken, Camerin A. Kirkwood, Carl D. Kumar, Ramya Vannice, Kirsten S. Stewart, Barclay T. BMC Public Health Research INTRODUCTION: Hepatitis E virus (HEV) is the most common cause of acute hepatitis. While symptoms are generally mild and resolve within weeks, some populations (e.g., pregnant women, immunocompromised adults) are at high-risk of severe HEV-related morbidity and mortality. There has not been a recent comprehensive review of contemporary HEV outbreaks, which limits the validity of current disease burden estimates. Therefore, we aimed to characterize global HEV outbreaks and describe data gaps to inform HEV outbreak prevention and response initiatives. METHODS: We performed a systematic review of peer-reviewed (PubMed, Embase) and gray literature (ProMED) to identify reports of outbreaks published between 2011 and 2022. We included (1) reports with ≥ 5 cases of HEV, and/or (2) reports with 1.5 times the baseline incidence of HEV in a specific population, and (3) all reports with suspected (e.g., clinical case definition) or confirmed (e.g., ELISA or PCR test) cases if they met criterium 1 and/or 2. We describe key outbreak epidemiological, prevention and response characteristics and major data gaps. RESULTS: We identified 907 records from PubMed, 468 from Embase, and 247 from ProMED. We screened 1,362 potentially relevant records after deduplication. Seventy-one reports were synthesized, representing 44 HEV outbreaks in 19 countries. The populations at risk, case fatalities, and outbreak durations were not reported in 66% of outbreak reports. No reports described using HEV vaccines. Reported intervention efforts included improving sanitation and hygiene, contact tracing/case surveillance, chlorinating boreholes, and advising residents to boil water. Commonly missing data elements included specific case definitions used, testing strategy and methods, seroprevalence, impacts of interventions, and outbreak response costs. Approximately 20% of HEV outbreaks we found were not published in the peer-reviewed literature. CONCLUSION: HEV represents a significant public health problem. Unfortunately, extensive data shortages and a lack of standardized reporting make it difficult to estimate the HEV disease burden accurately and to implement effective prevention and response activities. Our study has identified major gaps to guide future studies and outbreak reporting systems. Our results support the development of standardized reporting procedures/platforms for HEV outbreaks to ensure accurate and timely data distribution, including active and passive coordinated surveillance systems, particularly among high-risk populations. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-023-15792-8. BioMed Central 2023-06-12 /pmc/articles/PMC10259355/ /pubmed/37308896 http://dx.doi.org/10.1186/s12889-023-15792-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Al-Shimari, Fatima H. Rencken, Camerin A. Kirkwood, Carl D. Kumar, Ramya Vannice, Kirsten S. Stewart, Barclay T. Systematic review of global hepatitis E outbreaks to inform response and coordination initiatives |
title | Systematic review of global hepatitis E outbreaks to inform response and coordination initiatives |
title_full | Systematic review of global hepatitis E outbreaks to inform response and coordination initiatives |
title_fullStr | Systematic review of global hepatitis E outbreaks to inform response and coordination initiatives |
title_full_unstemmed | Systematic review of global hepatitis E outbreaks to inform response and coordination initiatives |
title_short | Systematic review of global hepatitis E outbreaks to inform response and coordination initiatives |
title_sort | systematic review of global hepatitis e outbreaks to inform response and coordination initiatives |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259355/ https://www.ncbi.nlm.nih.gov/pubmed/37308896 http://dx.doi.org/10.1186/s12889-023-15792-8 |
work_keys_str_mv | AT alshimarifatimah systematicreviewofglobalhepatitiseoutbreakstoinformresponseandcoordinationinitiatives AT renckencamerina systematicreviewofglobalhepatitiseoutbreakstoinformresponseandcoordinationinitiatives AT kirkwoodcarld systematicreviewofglobalhepatitiseoutbreakstoinformresponseandcoordinationinitiatives AT kumarramya systematicreviewofglobalhepatitiseoutbreakstoinformresponseandcoordinationinitiatives AT vannicekirstens systematicreviewofglobalhepatitiseoutbreakstoinformresponseandcoordinationinitiatives AT stewartbarclayt systematicreviewofglobalhepatitiseoutbreakstoinformresponseandcoordinationinitiatives |